ArticleiScience2023

Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy.

Li-Na He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.